Kolexia
Biron Amélie Gastro-entérologie
Biron Amélie
Gastro-entérologie
Hôpital Pierre Zobda-Quitman
Fort-de-France, France
53 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Colite Rectocolite hémorragique Nécrose Syndrome des ovaires polykystiques Ectromélie Endométriose Rhumatismes

Collaborateurs

Voir plus
Cadiot Guillaume
Cadiot Guillaume
Hôpital Robert-Debré Reims, Reims, France
Laurent-Badr Quentin
Laurent-Badr Quentin
Hôpital Robert-Debré Reims, Reims, France
Brixi Hedia
Brixi Hedia
Hôpital Robert-Debré Reims, Reims, France
Pitta Anais
Pitta Anais
Maison Blanche, Reims, France

Industries

Voir plus
Abbvie
18 collaboration(s)
Dernière en 2023
Amgen
5 collaboration(s)
Dernière en 2023
Janssen
5 collaboration(s)
Dernière en 2022
Galapagos SASU
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
P443 Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
P638 Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn’s disease: a GETAID multicentre cohort study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
DOP89 Impact of biologics on the risk of early postoperative complications in Crohn’s disease: a French nationwide study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study.
Alimentary pharmacology & therapeutics   19 décembre 2022
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study.
Journal of Crohn's & colitis   03 novembre 2022
Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease.
Alimentary pharmacology & therapeutics   04 juillet 2022
External evaluation of population pharmacokinetic models of infliximab and application for Bayes-based dosing in the clinical setting
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 14–16 June 2022, Lille, France   05 juin 2022
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
Digestive diseases and sciences   04 mars 2022
P140 Immunomodulators are protective against severe COVID 19: results from a large multicentre cohort of inflammatory bowel disease patients
Abstracts of the 17th Congress of ECCO Virtual February 16-19, 2022   21 janvier 2022
P350 Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study
Abstracts of the 17th Congress of ECCO Virtual February 16-19, 2022   21 janvier 2022